Self-adjuvanting therapeutic peptide-based vaccine induce CD8+ cytotoxic T lymphocyte responses in a murine human papillomavirus tumor model

Current Drug Delivery

Volumn 12, Issue 1, 2015, Pages 3-8

  Liu, Tzu Yu ^a   Giddam, Ashwini Kumar ^a   Hussein, Waleed M ^a   Jia, Zhongfan ^a   McMillan, Nigel A J ^b   Monteiro, Michael J ^a   Toth, Istvan ^a   Skwarczynski, Mariusz ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

Author keywords

Cytotoxic T lymphocyte (CTL) responses; Human papillomavirus; Peptide subunit vaccine; polyacrylate; Selfadjuvanting; Star polymer; Therapeutic anticancer vaccine

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; EPITOPE; GLUTAMINYLALANYLGLUTAMYLPROLYLASPARTYLARGINYLALANYLHISTIDYLTYROSYLASPARAGINYLISOLEUCYLVALYLTHREONYLPHENYLALANINE; OLIGOPEPTIDE; PEPTIDE VACCINE; POLYACRYLIC ACID; POLYMER; PROTEIN E7; UNCLASSIFIED DRUG; ACRYLIC ACID RESIN; CANCER VACCINE; CARBOPOL 940; DRUG CARRIER; IMMUNOLOGICAL ADJUVANT; ONCOGENE PROTEIN E7, HUMAN PAPILLOMAVIRUS TYPE 16; WART VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DRUG CONJUGATION; DRUG MECHANISM; DRUG STRUCTURE; DRUG UPTAKE; FEMALE; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNE RESPONSE; LUNG CANCER; MACROPHAGE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; TUMOR MODEL; ANIMAL; C57BL MOUSE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; IMMUNIZATION; IMMUNOLOGY; LUNG NEOPLASMS; MEDICINAL CHEMISTRY; PAPILLOMAVIRUS INFECTIONS; PHARMACEUTICS; PROCEDURES; TUMOR CELL LINE; VIROLOGY;

ACRYLIC RESINS; ADJUVANTS, IMMUNOLOGIC; ANIMALS; CANCER VACCINES; CELL LINE, TUMOR; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; EPITOPES; FEMALE; IMMUNIZATION; LUNG NEOPLASMS; MICE, INBRED C57BL; MOLECULAR STRUCTURE; PAPILLOMAVIRUS E7 PROTEINS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; T-LYMPHOCYTES, CYTOTOXIC; TECHNOLOGY, PHARMACEUTICAL;

EID: 84930898119     PISSN: 15672018     EISSN: 18755704     Source Type: Journal    
DOI: 10.2174/1567201811666141001155729     Document Type: Article

References (32)

1. Liu, T. Y.; Hussein, W. M.; Toth, I.; Skwarczynski, M. Advances in peptide-based human papillomavirus therapeutic vaccines. Curr. Top. Med. Chem., 2012, 12, 1581-1592.
2. Reed, S. G.; Bertholet, S.; Coler, R. N.; Friede, M. New horizons in adjuvants for vaccine development. Trends Immunol., 2009, 30, 23-32.
3. Sharma, R. K.; Elpek, K. G.; Yolcu, E. S.; Schabowsky, R. H.; Zhao, H.; Bandura-Morgan, L.; Shirwan, H. Costimulation as a platform for the development of vaccines: a peptide-based vaccine containing a novel form of 4-1BB ligand eradicates established tumors. Cancer Res., 2009, 69, 4319-4326.
4. Guy, B. The perfect mix: recent progress in adjuvant research. Nat. Rev. Microbiol., 2007, 5, 505-517.
5. Palena, C.; Schlom, J. Vaccines against human carcinomas: strategies to improve antitumor immune responses. J. Biomed. Biotechnol., 2010, 2010, 380697.
6. Zaman, M.; Skwarczynski, M.; Malcolm, J. M.; Urbani, C. N.; Jia, Z. F.; Batzloff, M. R.; Good, M. F.; Monteiro, M. J.; Toth, I. Selfadjuvanting polyacrylic nanoparticulate delivery system for group A streptococcus (GAS) vaccine. Nanomedicine, 2011, 7, 168-173.
7. Skwarczynski, M.; Zaman, M.; Urbani, C. N.; Lin, I. C.; Jia, Z.; Batzloff, M. R.; Good, M. F.; Monteiro, M. J.; Toth, I. Polyacrylate dendrimer nanoparticles: a self-adjuvanting vaccine delivery system. Angew. Chem. Int. Ed. Engl., 2010, 49, 5742-5745.
8. Ahmad Fuaad, A. A.; Jia, Z.; Zaman, M.; Hartas, J.; Ziora, Z. M.; Lin, I. C.; Moyle, P. M.; Batzloff, M. R.; Good, M. F.; Monteiro, M. J.; Skwarczynski, M.; Toth, I. Polymer-peptide hybrids as a highly immunogenic single-dose nanovaccine. Nanomedicine (Lond), 2014, 9, 35-43.
9. Liu, T. Y.; Hussein, W. M.; Jia, Z.; Ziora, Z. M.; McMillan, N. A.; Monteiro, M. J.; Toth, I.; Skwarczynski, M. Self-Adjuvanting Polymer-Peptide Conjugates As Therapeutic Vaccine Candidates against Cervical Cancer. Biomacromolecules, 2013, 14, 2798-2806.
10. Liu, T. Y.; Ahmad, F. A. A.; Toth, I.; Skwarczynski, M. Selfassembled peptide-polymer conjugates as vaccines. Chim. Oggi/Chem. Today, 2014, 32, 18-22.
11. Jia, Z.; Bell, C. A.; Monteiro, M. J. Rapid and Highly Efficient Functionalization of Polymer Bromide End-Groups by SET-NRC. Macromolecules, 2011, 44, 1747-1751.
12. Ahmad Fuaad, A. A.; Azmi, F.; Skwarczynski, M.; Toth, I. Peptide conjugation via CuAAC 'click' chemistry. Molecules, 2013, 18, 13148-13174.
13. da Fonseca, L. S.; Silveira, R. P.; Deboni, A. M.; Benvenutti, E. V.; Costa, T. M.; Guterres, S. S.; Pohlmann, A. R. Nanocapsule@xerogel microparticles containing sodium diclofenac: a new strategy to control the release of drugs. Int. J. Pharm., 2008, 358, 292-295.
14. Kim, H. J.; Yang, J. S.; Woo, S. S.; Kim, S. K.; Yun, C. H.; Kim, K. K.; Han, S. H. Lipoteichoic acid and muramyl dipeptide synergistically induce maturation of human dendritic cells and concurrent expression of proinflammatory cytokines. J. Leukoc. Biol., 2007, 81, 983-989.
15. White, K. L.; Rades, T.; Furneaux, R. H.; Tyler, P. C.; Hook, S. Mannosylated liposomes as antigen delivery vehicles for targeting to dendritic cells. J. Pharm. Pharmacol., 2006, 58, 729-737.
16. Lin, K. Y.; Guarnieri, F. G.; Staveley-O'Carroll, K. F.; Levitsky, H. I.; August, J. T.; Pardoll, D. M.; Wu, T. C. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res., 1996, 56, 21-26.
17. Zeng, Q.; Peng, S.; Monie, A.; Yang, M.; Pang, X.; Hung, C. F.; Wu, T. C. Control of cervicovaginal HPV-16 E7-expressing tumors by the combination of therapeutic HPV vaccination and vascular disrupting agents. Hum. Gene Ther., 2011, 22, 809-819.
18. Lin, C. C.; Chou, C. W.; Shiau, A. L.; Tu, C. F.; Ko, T. M.; Chen, Y. L.; Yang, B. C.; Tao, M. H.; Lai, M. D. Therapeutic HER2/Neu DNA vaccine inhibits mouse tumor naturally overexpressing endogenous neu. Mol. Ther., 2004, 10, 290-301.
19. Teng, M. W.; Swann, J. B.; von Scheidt, B.; Sharkey, J.; Zerafa, N.; McLaughlin, N.; Yamaguchi, T.; Sakaguchi, S.; Darcy, P. K.; Smyth, M. J. Multiple antitumor mechanisms downstream of prophylactic regulatory T-cell depletion. Cancer Res., 2010, 70, 2665-2674.
20. Skwarczynski, M.; Parhiz, B. H.; Soltani, F.; Srinivasan, S.; Kamaruzaman, K. A.; Lin, I. C.; Toth, I. Lipid peptide core nanoparticles as multivalent vaccine candidates against Streptococcus pyogenes. Aust. J. Chem., 2012, 65, 35-39.
21. Tindle, R. W.; Croft, S.; Herd, K.; Malcolm, K.; Geczy, A. F.; Stewart, T.; Fernando, G. J. A vaccine conjugate of 'ISCAR' immunocarrier and peptide epitopes of the E7 cervical cancerassociated protein of human papillomavirus type 16 elicits specific Th1-and Th2-type responses in immunized mice in the absence of oil-based adjuvants. Clin. Exp. Immunol., 1995, 101, 265-271.
22. Boas, U.; Heegaard, P. M. Dendrimers in drug research. Chem. Soc. Rev., 2004, 33, 43-63.
23. Hilgers, L. A.; Ghenne, L.; Nicolas, I.; Fochesato, M.; Lejeune, G.; Boon, B. Alkyl-polyacrylate esters are strong mucosal adjuvants. Vaccine, 2000, 18, 3319-3325.
24. Hilgers, L. A.; Nicolas, I.; Lejeune, G.; Dewil, E.; Strebelle, M.; Boon, B. Alkyl-esters of polyacrylic acid as vaccine adjuvants. Vaccine, 1998, 16, 1575-1581.
25. Giddam, A. K.; Zaman, M.; Skwarczynski, M.; Toth, I. Liposomebased delivery system for vaccine candidates: constructing an effective formulation. Nanomedicine (Lond), 2012, 7, 1877-1893.
26. Skwarczynski, M.; Toth, I. Peptide-based subunit nanovaccines. Curr. Drug Deliv., 2011, 8, 282-289.
27. Uto, T.; Akagi, T.; Toyama, M.; Nishi, Y.; Shima, F.; Akashi, M.; Baba, M. Comparative activity of biodegradable nanoparticles with aluminum adjuvants: antigen uptake by dendritic cells and induction of immune response in mice. Immunol. Lett., 2011, 140, 36-43.
28. Oyewumi, M. O.; Kumar, A.; Cui, Z. Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses. Expert Rev. Vaccines, 2010, 9, 1095-1107.
29. Sarkar, A. K.; Tortolero-Luna, G.; Nehete, P. N.; Arlinghaus, R. B.; Mitchell, M. F.; Sastry, K. J. Studies on in vivo induction of cytotoxic T lymphocyte responses by synthetic peptides from E6 and E7 oncoproteins of human papillomavirus type 16. Viral Immunol., 1995, 8, 165-174.
30. Bijker, M. S.; van den Eeden, S. J.; Franken, K. L.; Melief, C. J.; Offringa, R.; van der Burg, S. H. CD8+ CTL priming by exact peptide epitopes in incomplete Freund's adjuvant induces a vanishing CTL response, whereas long peptides induce sustained CTL reactivity. J. Immunol., 2007, 179, 5033-5040.
31. Bachmann, M. F.; Jennings, G. T. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat. Rev. Immunol., 2010, 10, 787-796.
32. Manolova, V.; Flace, A.; Bauer, M.; Schwarz, K.; Saudan, P.; Bachmann, M. F. Nanoparticles target distinct dendritic cell populations according to their size. Eur. J. Immunol., 2008, 38, 1404-1413.